skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration



Our client asked us to help support their CNS product portfolio strategy by helping to understand the clinical and commercial potential of the schizophrenia market



  • Our team evaluated the market opportunity by:
  • Mapping clinical pathways and patient segments
  • Providing a detailed characterization of the current competitive landscape
  • Mapping high probability/high impact future market trends
  • Modeling the implications of market events on the overall market, as well as our client’s product portfolio
  • Assessing pricing and reimbursement potential
  • We worked with our client to design a comprehensive research program that included:
  • 26 KOL interviews and survey completed by 252 treating psychiatrists distributed across the US, EU, and Japan




Our Consultants delivered a comprehensive overview of the market, products and stakeholders, along with a product attribute analysis, product forecast, and pricing & reimbursement potential for the US, EU, and JP


Next steps

For a personal discussion, please contact Richard Veal:

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: